Skip to main content

Table 1 Demographic, clinical and biological characteristics of the sample

From: Vascular structure and function and their relationship with health-related quality of life in the MARK study

 

Mean/Median/Num

SD/IQR/(%).

Age

60.48

8.52

Gender (women) n (%)

153

(50.5)

Smoker n (%)

64

(21.1)

Alcohol drinking (g/week)

30

0–90

METs-min/14 days

3536.56

3395.87

Diet quality index

31.30

2.73

Systolic blood pressure (mmHg)

132.96

15.80

Diastolic blood pressure (mmHg)

80.13

10.26

Mean blood pressure (mmHg)

97.74

10.91

Heartrate (bpm)

64.60

10.20

Total Cholesterol (mg/dl)

220.60

38.40

LDL Cholesterol (mg/dl)

139.09

34.26

HDL-Cholesterol (mg/dl)

56.43

14.20

Triglycerides (mg/dl)

106

78–144

Atherogenic index

4.13

1.19

Glycaemia (mg/dl)

88

91–98

HbA1c %

5.6

5.4–6.0

Creatinine (mg/dl)

0.85

0.18

ABI

1.09

0.07

ba-PWV (m/s)

14.64

2.55

ba-PWV > 17.5 m/s n (%)

39

(12.9)

CAVI

8.61

1.08

CAVI categories. n (%)

<8

90

(29.7)

 

8–9

102

(33.7)

 

>9

111

(36.6)

AIx_75 %

 

26.46

14.05

Hypertensive patients n (%)

230

(75.9)

Diabetic patients n (%)

73

(24.1)

Obesity patients n (%)

81

(26.7)

Antihypertensive drugs n (%)

146

(48.2)

Antidiabetic drugs n (%)

41

(13.5)

Lipid lowering drugs n (%)

107

(35.3)

  1. METs Metabolic equivalent, Atherogenic index: Total Cholesterol/HDL-Cholesterol, ABI Ankle brachial index, ba-PWV Brachial-Ankle Pulse Wave Velocity. CAVI Cardio Ankle Vascular index, AIx_75 Augmentation Index adjusted 75 bpm, SD Standard Deviation, IQR Interquartile Range